CancerNetwork Members: Login | Register
 


 

Order Your Copy!
(2010, 13th Edition)

 


 

Please allow 3 – 4 weeks to ship

Gastrointestinal Stromal Tumor

  • 58-Year-Old Male Presents With Stomach Mass

    TEST YOUR IMAGE IQ
    A 58-year-old male presents with complaints of bloating, vague abdominal pain, and dark black stools. A gastroenterologist recommends upper and lower endoscopy. A mass of about 11×12 mm is removed from the stomach. The most likely diagnosis is:
    A. Desmoid tumor
    B. Inflammatory fibroid polyp
    C. Schwannoma
    D. Gastrointestinal stromal tumor


  • Mark Kris speaking at ASCO 2011

    GIST News from the 2011 ASCO Annual Meeting

    CONFERENCE REPORT
    Dr. Mark Kris discusses the news highlighted at ASCO's 2011 Annual Meeting that covers research on managing cancer as a chronic disease, and includes information on advances in treatment for gastrointestinal stromal tumors (GIST). Video source: cancer.net


  • Before and After CT Scan of GIST Patient Using Therapy

    Archives: Imatinib Mesylate

    REVIEW ARTICLE Oncology Vol. 17 No. 11
    The molecular and genomic determinants of response/resistance patterns are the subject of ongoing studies, and adjuvant studies are also under way. The initial evaluations of imatinib provide proof of concept for the hypothesis-driven design of selective molecularly targeted therapies for solid tumor malignancies.

    • Commentary (Blanke)• Commentary (Palesty et al)

  • Image source: Wikimedia Commons user KGH

    Perioperative Treatment of GIST

    REVIEW ARTICLE Oncology Vol. 23 No. 1
    This review describes the current multidisciplinary management of gastrointestinal stromal tumor (GIST), which is the most common sarcoma of the gastrointestinal tract. Before 2001, surgery was the only effective therapy for GIST.

    • Perioperative Tyrosine Kinase Inhibitors for GIST: Further Investigation?
    • Controversies in the Surgical Management of GIST in the Era of Imatinib

  • Endoscopy image of GIST; Image source: Wikimedia Commons user Samir

    New Therapeutic Options in GIST

    REVIEW ARTICLE Oncology Vol. 22 No. 2
    The impact of neoadjuvant drug therapy needs to be further classified and explored. With additional evaluation of other tyrosine kinase inhibitors and novel therapies against other molecular markers, the treatment paradigm for this malignancy should continue to evolve.

    • Treatment of GIST: Clarifying the Data



 
   SEARCH MEDICA RX
   Browse drugs by name:
A B C D E F G H I J
K L M N O P Q R S T
U V W X Y Z All      
   Search for drugs:

 


CancerNetwork on Facebook